• Login
    View Item 
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Bio-Medical Sciences (Bio-Medical)
    • School of Bio-Medical Sciences (Bio-Medical) Collections
    • View Item
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Bio-Medical Sciences (Bio-Medical)
    • School of Bio-Medical Sciences (Bio-Medical) Collections
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Evaluation of mycobacterium tuberculosis thymidylate kinase as diagnostic biomarker for pulmonary tuberculosis among HIV positive individuals at mjap- iss clinic.

    Thumbnail
    View/Open
    BABIRYE-CHS-MASTER.pdf (2.588Mb)
    Date
    2018-11-28
    Author
    BABIRYE, JANET PEACE
    Metadata
    Show full item record
    Abstract
    Background Tuberculosis (TB) is the leading cause of morbidity & mortality among HIV positive individuals. Diagnosis of TB in context of HIV co-infection remains challenging. Mycobacterium tuberculosis (M.tb) thymidylate kinase (TMKmt) has been validated as a novel biomarker with high detection limit for TB in sputum. This study was carried out to evaluate TMKmt as a diagnostic biomarker for pulmonary tuberculosis among HIV positive individuals at Makerere University Joint AIDS Program (MJAP) ISS clinic. Methods A total of 120 participants with presumptive pulmonary tuberculosis were enrolled in a cross sectional study at the MJAP ISS clinic between May and August 2018. Venous blood and expectorated spot sputum were obtained from 116 consenting participants. M.tb culture was performed on sputum as the gold standard to confirm TB status while direct ELISAs were performed on sputum and serum to determine the level of TMKmt antigen. TMKmt levels were analyzed using t test set at a significant level (P<0.05). Sensitivity and specificity and receiver operator characteristic curves were used to assess the precision of TMKmt in diagnosing PTB. Results Of the 116 participants, only 22 (19%) were TB positive based on either LJ or MGIT culture. The mean sputum TMKmt levels were significantly higher in TB positive individuals (4.889 ± 0.135) ng/ml as compared to TB negative individuals (4.303 ± 0.07295) ng/ml (t-test, P<0.0005). At a cut off value of > 4.683 ng/ml, the test had a sensitivity of 73% (95% CI, 49.78% - 89.27%) and a specificity of 72% (95% CI, 62.15% - 81.07%). These results were supported by a receiver operator analysis which showed an area under the curve (AUC) of 0.75 (95% CI, 0.63 – O.86). There was no significant difference in the mean serum TMKmt levels between TB negative and TB positive individuals. Conclusion Sputum TMKmt is a very good diagnostic biomarker for active pulmonary tuberculosis. This forms an alternate test to replace smear microscopy and overcome the current TB diagnostic challenges.
    URI
    http://hdl.handle.net/10570/6903
    Collections
    • School of Bio-Medical Sciences (Bio-Medical) Collections

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of Mak IRCommunities & CollectionsTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy TypeThis CollectionTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV